首页 > 最新文献

Andrology最新文献

英文 中文
A comprehensive review on p38MAPK signaling as a potent radioprotector in testis 全面回顾 p38MAPK 信号在睾丸中的强效辐射保护作用
IF 4.5 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-17 DOI: 10.1111/andr.13760
Juan Yang, Xiangying Ou, Huihong Zeng, Lijian Shao
BackgroundPrevious studies have shown that the activation of p38MAPK signaling plays a crucial role in regulating gonadal cell fate decisions in both mouse and human. Excessive activation of p38MAPK by radiation significantly causes testicular damage and negatively affects the male reproductive function. Therefore, fine‐tuned regulation of p38MAPK signaling is critical in both physiological and pathological conditions.ResultThis review summarizes the impact of p38MAPK signaling on testicular germ cells and microenvironment under normal condition. The relationship between radiation, reactive oxygen species (ROS), and p38MAPK is summarized. In conclusion, radiation exposure triggers the overactivation of p38MAPK, which is regulated by ROS, resulting in testicular damage. Various p38MAPK‐targeting agents are discussed, providing guidance for developing new strategies.
背景以前的研究表明,p38MAPK 信号的激活在调节小鼠和人类性腺细胞命运决定方面起着至关重要的作用。辐射对 p38MAPK 的过度激活会导致睾丸损伤,并对男性生殖功能产生负面影响。本综述总结了正常情况下 p38MAPK 信号转导对睾丸生殖细胞和微环境的影响。综述了辐射、活性氧(ROS)和p38MAPK之间的关系。总之,辐照会引发 p38MAPK 的过度激活,而 p38MAPK 又受 ROS 的调控,从而导致睾丸损伤。本文讨论了各种 p38MAPK 靶向药物,为制定新策略提供了指导。
{"title":"A comprehensive review on p38MAPK signaling as a potent radioprotector in testis","authors":"Juan Yang, Xiangying Ou, Huihong Zeng, Lijian Shao","doi":"10.1111/andr.13760","DOIUrl":"https://doi.org/10.1111/andr.13760","url":null,"abstract":"BackgroundPrevious studies have shown that the activation of p38MAPK signaling plays a crucial role in regulating gonadal cell fate decisions in both mouse and human. Excessive activation of p38MAPK by radiation significantly causes testicular damage and negatively affects the male reproductive function. Therefore, fine‐tuned regulation of p38MAPK signaling is critical in both physiological and pathological conditions.ResultThis review summarizes the impact of p38MAPK signaling on testicular germ cells and microenvironment under normal condition. The relationship between radiation, reactive oxygen species (ROS), and p38MAPK is summarized. In conclusion, radiation exposure triggers the overactivation of p38MAPK, which is regulated by ROS, resulting in testicular damage. Various p38MAPK‐targeting agents are discussed, providing guidance for developing new strategies.","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"1 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies 解读睾丸生殖细胞肿瘤的免疫学改变:从免疫平衡到恶性肿瘤和新兴免疫疗法
IF 4.5 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-10 DOI: 10.1111/andr.13751
Hadiseh Farahani, Reza Darvishvand, Aida Khademolhosseini, Nasrollah Erfani
BackgroundTesticular germ cell tumors (TGCTs), derived from primordial germ cells, are rare malignancies with high curative potential. However, the emergence of new evidence indicating that 15% of patients experience tumor progression, leading to death, underscores the need for innovative therapeutics.ObjectivesThis review aimed to explore the immune status in maintaining testicular health and the immune‐related aspects of malignancy. Furthermore, it presents an overview of current data on the use of immunotherapy for TGCT patients.Results DiscussionRecent advances in immunology have opened a promising avenue for studying diseases and highlighted its role in treating diseases. While the immunopathological facets of TGCTs are not fully understood, investigations suggest a complex interplay among testis‐resident immune cells, testis‐specific cells (i.e., Sertoli cells (SCs) and Leydig cells (LCs)), and immune‐regulating mediators (e.g., sex hormones) in the normal testicle that foster the testicular immune privilege (TIP). Although TIP plays a crucial role in sperm production, it also makes testis vulnerable to tumor development. In the context of cancer‐related inflammation, disruption of TIP leads to an imbalanced immune response, resulting in chronic inflammation that can contribute to testicular tissue dysfunction or loss, potentially aiding in cancer invasion and progression.ConclusionComparing the immune profiles of normal and malignant testes is valuable and may provide insights into different aspects of testicular immunity and immune‐based treatment approaches. For patients resistant to chemotherapy and with a poor prognosis, immunotherapy has shown promising results. However, its effectiveness in treating resistant TGCTs or preventing tumor recurrence is still uncertain.
背景睾丸生殖细胞瘤(TGCT)源自原始生殖细胞,是一种罕见的恶性肿瘤,具有很高的治愈潜力。本综述旨在探讨维持睾丸健康的免疫状态以及恶性肿瘤的免疫相关方面。结果 讨论免疫学的最新进展为研究疾病开辟了一条前景广阔的途径,并凸显了其在治疗疾病中的作用。尽管TGCT的免疫病理机制尚未完全明了,但研究表明,睾丸驻留的免疫细胞、睾丸特异性细胞(即Sertoli细胞(SC)和Leydig细胞(LC))以及正常睾丸中的免疫调节介质(如性激素)之间存在着复杂的相互作用,从而形成了睾丸免疫特权(TIP)。尽管 TIP 在精子生成过程中发挥着至关重要的作用,但它也使睾丸易受肿瘤发展的影响。在与癌症相关的炎症背景下,TIP 的破坏会导致免疫反应失衡,造成慢性炎症,从而导致睾丸组织功能障碍或丧失,并有可能助长癌症的侵袭和发展。对于化疗耐药且预后不良的患者,免疫疗法已显示出良好的效果。然而,免疫疗法在治疗耐药的TGCT或预防肿瘤复发方面的有效性仍不确定。
{"title":"Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies","authors":"Hadiseh Farahani, Reza Darvishvand, Aida Khademolhosseini, Nasrollah Erfani","doi":"10.1111/andr.13751","DOIUrl":"https://doi.org/10.1111/andr.13751","url":null,"abstract":"BackgroundTesticular germ cell tumors (TGCTs), derived from primordial germ cells, are rare malignancies with high curative potential. However, the emergence of new evidence indicating that 15% of patients experience tumor progression, leading to death, underscores the need for innovative therapeutics.ObjectivesThis review aimed to explore the immune status in maintaining testicular health and the immune‐related aspects of malignancy. Furthermore, it presents an overview of current data on the use of immunotherapy for TGCT patients.Results DiscussionRecent advances in immunology have opened a promising avenue for studying diseases and highlighted its role in treating diseases. While the immunopathological facets of TGCTs are not fully understood, investigations suggest a complex interplay among testis‐resident immune cells, testis‐specific cells (i.e., Sertoli cells (SCs) and Leydig cells (LCs)), and immune‐regulating mediators (e.g., sex hormones) in the normal testicle that foster the testicular immune privilege (TIP). Although TIP plays a crucial role in sperm production, it also makes testis vulnerable to tumor development. In the context of cancer‐related inflammation, disruption of TIP leads to an imbalanced immune response, resulting in chronic inflammation that can contribute to testicular tissue dysfunction or loss, potentially aiding in cancer invasion and progression.ConclusionComparing the immune profiles of normal and malignant testes is valuable and may provide insights into different aspects of testicular immunity and immune‐based treatment approaches. For patients resistant to chemotherapy and with a poor prognosis, immunotherapy has shown promising results. However, its effectiveness in treating resistant TGCTs or preventing tumor recurrence is still uncertain.","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"24 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142185808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aloperine protects the testis against testicular ischemia/reperfusion injury in rats 阿洛哌啶能保护大鼠睾丸免受睾丸缺血再灌注损伤的伤害
IF 4.5 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-10 DOI: 10.1111/andr.13750
Shichao Wei, Junshen Xiao, Feng Ju, Zhaoyang Hu
BackgroundTesticular torsion/detorsion can cause testis loss and infertility. Aloperine is a major active alkaloid extracted from Sophora alopecuroides Linn. It has been shown to have organ‐protective effects. However, the effects of aloperine on the testis and its underlying mechanisms remain unclear.ObjectivesThis study investigated the effect of aloperine on testicular torsion/detorsion injury in rats.Materials and MethodsMale Sprague‐Dawley rats were randomized to the sham‐operated (sham), testicular I/R (TI/R), or aloperine preconditioning (ALOPre) or postconditioning (ALOPost) groups. All rats except for the sham‐operated rats were subjected to 3 h of right spermatic cord torsion (720°, clockwise), followed by 3 h of detorsion. Aloperine (10 mg/kg) was intravenously administered before testicular torsion (ALOPre) or at the onset of testicular detorsion (ALOPost). The therapeutic efficacy of aloperine was evaluated by histological analysis, oxidative stress evaluation, inflammatory response examination, apoptosis analysis, protein analysis, and immunohistological assessment.ResultsCompared with TI/R, aloperine protected both the ipsilateral and contralateral testes against unilateral testicular I/R, as evidenced by a reduced testicular weight to body weight (TW/BW) ratio (ALOPre: p = 0.0037; ALOPost: p = 0.0021) and volume (ALOPre: p = 0.0020; ALOPost: p = 0.0009), less structural damage with better Johnsen (ALOPre: p = 0.0013; ALOPost: p = 0.0021), and Cosentino scores (ALOPre: p < 0.0001; ALOPost: p < 0.0001), increased mean seminiferous tubule diameter and mean seminiferous tubule epithelial height, decreased testicular apoptosis, and less oxidative stress and inflammatory response. In addition, aloperine significantly stimulated the phosphorylation of signal transducer and activator of transcription (STAT)‐3 in the ipsilateral testes following detorsion. Administration of Ag490 suppressed STAT‐3 phosphorylation, thereby abrogating the protective effects exerted by aloperine on the ipsilateral testis.Discussion and ConclusionAloperine has a strong testicular protective effect on the ipsilateral and contralateral testes after testicular torsion/detorsion. This aloperine‐induced ipsilateral testicular protection is mediated via the STAT‐3 signaling pathway.
背景睾丸扭转/脱出可导致睾丸缺失和不育。阿洛哌啶是从槐属植物中提取的一种主要活性生物碱。它已被证明具有器官保护作用。材料和方法将雄性 Sprague-Dawley 大鼠随机分为假手术组(sham)、睾丸 I/R 组(TI/R)、阿洛哌林预处理组(ALOPre)或后处理组(ALOPost)。除假手术大鼠外,所有大鼠均接受 3 小时的右侧精索扭转(720°,顺时针方向),然后再进行 3 小时的扭转。在睾丸扭转前(ALOPre)或睾丸扭转开始时(ALOPost)静脉注射阿洛哌嗪(10 毫克/千克)。通过组织学分析、氧化应激评估、炎症反应检查、细胞凋亡分析、蛋白质分析和免疫组织学评估来评价阿洛哌啶的疗效。结果与 TI/R 相比,阿洛哌啶能保护同侧和对侧睾丸免受单侧睾丸 I/R 的损伤,这体现在睾丸重量与体重(TW/BW)比值降低(ALOPre:p = 0.0037;ALOPost:p = 0.0021)和体积(ALOPre:p = 0.0020;ALOPost:p = 0.0009),较少的结构性损伤,较好的约翰森(Johnsen)(ALOPre:p = 0.0013;ALOPost:p = 0.0021)和科森蒂诺(Cosentino)评分(ALOPre:p < 0.0001;ALOPost:p <;0.0001),曲细精管平均直径和曲细精管上皮平均高度增加,睾丸凋亡减少,氧化应激和炎症反应减轻。此外,阿洛哌嗪还能明显刺激离体后同侧睾丸中信号转导和转录激活因子(STAT)-3的磷酸化。讨论和结论 阿洛哌啶对睾丸扭转/脱落后的同侧和对侧睾丸有很强的保护作用。阿洛哌啶诱导的同侧睾丸保护作用是通过 STAT-3 信号通路介导的。
{"title":"Aloperine protects the testis against testicular ischemia/reperfusion injury in rats","authors":"Shichao Wei, Junshen Xiao, Feng Ju, Zhaoyang Hu","doi":"10.1111/andr.13750","DOIUrl":"https://doi.org/10.1111/andr.13750","url":null,"abstract":"BackgroundTesticular torsion/detorsion can cause testis loss and infertility. Aloperine is a major active alkaloid extracted from <jats:italic>Sophora alopecuroides</jats:italic> Linn. It has been shown to have organ‐protective effects. However, the effects of aloperine on the testis and its underlying mechanisms remain unclear.ObjectivesThis study investigated the effect of aloperine on testicular torsion/detorsion injury in rats.Materials and MethodsMale Sprague‐Dawley rats were randomized to the sham‐operated (sham), testicular I/R (TI/R), or aloperine preconditioning (ALOPre) or postconditioning (ALOPost) groups. All rats except for the sham‐operated rats were subjected to 3 h of right spermatic cord torsion (720°, clockwise), followed by 3 h of detorsion. Aloperine (10 mg/kg) was intravenously administered before testicular torsion (ALOPre) or at the onset of testicular detorsion (ALOPost). The therapeutic efficacy of aloperine was evaluated by histological analysis, oxidative stress evaluation, inflammatory response examination, apoptosis analysis, protein analysis, and immunohistological assessment.ResultsCompared with TI/R, aloperine protected both the ipsilateral and contralateral testes against unilateral testicular I/R, as evidenced by a reduced testicular weight to body weight (TW/BW) ratio (ALOPre: <jats:italic>p </jats:italic>= 0.0037; ALOPost: <jats:italic>p </jats:italic>= 0.0021) and volume (ALOPre: <jats:italic>p </jats:italic>= 0.0020; ALOPost: <jats:italic>p </jats:italic>= 0.0009), less structural damage with better Johnsen (ALOPre: <jats:italic>p </jats:italic>= 0.0013; ALOPost: <jats:italic>p </jats:italic>= 0.0021), and Cosentino scores (ALOPre: <jats:italic>p </jats:italic>&lt; 0.0001; ALOPost: <jats:italic>p </jats:italic>&lt; 0.0001), increased mean seminiferous tubule diameter and mean seminiferous tubule epithelial height, decreased testicular apoptosis, and less oxidative stress and inflammatory response. In addition, aloperine significantly stimulated the phosphorylation of signal transducer and activator of transcription (STAT)‐3 in the ipsilateral testes following detorsion. Administration of Ag490 suppressed STAT‐3 phosphorylation, thereby abrogating the protective effects exerted by aloperine on the ipsilateral testis.Discussion and ConclusionAloperine has a strong testicular protective effect on the ipsilateral and contralateral testes after testicular torsion/detorsion. This aloperine‐induced ipsilateral testicular protection is mediated via the STAT‐3 signaling pathway.","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"9 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142224414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism 十一酸睾酮口服液对性腺功能减退症男性的安全性、有效性和药代动力学研究
IF 4.5 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-10 DOI: 10.1111/andr.13747
Martin Miner, Christina Wang, Jed Kaminetsky, Mohit Khera, Irwin Goldstein, Culley Carson, Nachiappan Chidambaram, Shelby King, Adrian Dobs
BackgroundTestosterone deficiency results from insufficient testosterone production. Testosterone therapy may require dose titration to reach eugonadal serum testosterone concentrations.ObjectiveThe primary objective was the efficacy of oral testosterone undecanoate (TLANDO; Antares Pharma Inc.) in male patients with documented hypogonadism. Secondary objectives included a comparison of oral testosterone undecanoate safety and quality‐of‐life assessments to 1.62% topical testosterone gel (AndroGel 1.62%; AbbVie).Materials and methodsIn this phase 3 study, 315 patients were randomized 2:1 to oral testosterone undecanoate or 1.62% topical testosterone gel (NCT02081300). Patients received 225 mg oral testosterone undecanoate twice daily, and doses were adjusted by 75 mg/dose at weeks 4 and 8 based on average serum total testosterone concentration and maximum observed serum concentration. The primary endpoint was the proportion of patients receiving oral testosterone undecanoate with serum total testosterone concentration within the eugonadal reference range (300–1140 ng/dL). Secondary endpoints included the proportion of patients with maximum serum total testosterone concentrations within predetermined limits, safety parameters, and quality‐of‐life endpoints including the Short Form‐36v2 Health Survey, Psychosexual Daily Questionnaire, and International Prostate Symptom Score.ResultsOverall mean ± SD baseline testosterone was 205.7 ± 71.6 ng/dL. For patients receiving oral testosterone undecanoate, 87.4% demonstrated a 24‐h average serum total testosterone concentration within the reference range following titration. Oral testosterone undecanoate demonstrated a nominal statistically significantly greater mean change from baseline than 1.62% topical testosterone gel for Short Form‐36v2 Health Survey measures of mental health (2.91 vs. ‐0.10; p = 0.035), and mental component summary (3.82 vs. 0.55; p = 0.009); and Psychosexual Daily Questionnaire measure of weekly negative mood (‐0.57 vs. ‐0.20; p = 0.021). Safety endpoints were comparable between therapies. No deaths or treatment‐related serious adverse events were reported.Discussion and conclusionMale patients with hypogonadism receiving oral testosterone undecanoate 225 mg twice daily demonstrated improvements in libido and sexual frequency. Serum testosterone concentrations were within the reference range in 87% of patients without dose titration.
背景睾酮分泌不足导致睾酮缺乏症。目标首要目标是口服十一酸睾酮(TLANDO;Antares Pharma Inc.)对有记录的性腺功能减退症男性患者的疗效。次要目标包括将十一酸睾酮口服液的安全性和生活质量评估与 1.62% 的局部睾酮凝胶 (AndroGel 1.62%; AbbVie) 进行比较。患者每天两次口服 225 毫克十一酸睾酮,第 4 周和第 8 周根据平均血清总睾酮浓度和最大观察血清浓度调整 75 毫克/剂量。主要终点是接受十一酸睾酮口服治疗的患者中血清总睾酮浓度在优生参考范围(300-1140 ng/dL)内的比例。次要终点包括血清总睾酮浓度最高值在预定范围内的患者比例、安全性参数和生活质量终点,包括简表-36v2 健康调查、每日性心理问卷和国际前列腺症状评分。结果总平均值(± SD)基线睾酮为 205.7 ± 71.6 ng/dL。在接受十一酸睾酮口服治疗的患者中,87.4%的患者在滴定后 24 小时平均血清总睾酮浓度在参考范围内。与 1.62% 的局部睾酮凝胶相比,十一酸睾酮口服液在心理健康短表-36v2 健康调查测量(2.91 vs. -0.10;p = 0.035)和心理部分总结(3.82 vs. 0.55;p = 0.009);以及性心理日常问卷调查每周负面情绪测量(-0.57 vs. -0.20;p = 0.021)方面与基线相比的名义平均变化显著高于统计意义上的平均变化。两种疗法的安全性终点相当。讨论与结论男性性腺功能减退症患者口服十一酸睾酮225毫克,每天两次,性欲和性生活频率均有所改善。87%的患者血清睾酮浓度在参考范围内,无需剂量滴定。
{"title":"Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism","authors":"Martin Miner, Christina Wang, Jed Kaminetsky, Mohit Khera, Irwin Goldstein, Culley Carson, Nachiappan Chidambaram, Shelby King, Adrian Dobs","doi":"10.1111/andr.13747","DOIUrl":"https://doi.org/10.1111/andr.13747","url":null,"abstract":"BackgroundTestosterone deficiency results from insufficient testosterone production. Testosterone therapy may require dose titration to reach eugonadal serum testosterone concentrations.ObjectiveThe primary objective was the efficacy of oral testosterone undecanoate (TLANDO; Antares Pharma Inc.) in male patients with documented hypogonadism. Secondary objectives included a comparison of oral testosterone undecanoate safety and quality‐of‐life assessments to 1.62% topical testosterone gel (AndroGel 1.62%; AbbVie).Materials and methodsIn this phase 3 study, 315 patients were randomized 2:1 to oral testosterone undecanoate or 1.62% topical testosterone gel (NCT02081300). Patients received 225 mg oral testosterone undecanoate twice daily, and doses were adjusted by 75 mg/dose at weeks 4 and 8 based on average serum total testosterone concentration and maximum observed serum concentration. The primary endpoint was the proportion of patients receiving oral testosterone undecanoate with serum total testosterone concentration within the eugonadal reference range (300–1140 ng/dL). Secondary endpoints included the proportion of patients with maximum serum total testosterone concentrations within predetermined limits, safety parameters, and quality‐of‐life endpoints including the Short Form‐36v2 Health Survey, Psychosexual Daily Questionnaire, and International Prostate Symptom Score.ResultsOverall mean ± SD baseline testosterone was 205.7 ± 71.6 ng/dL. For patients receiving oral testosterone undecanoate, 87.4% demonstrated a 24‐h average serum total testosterone concentration within the reference range following titration. Oral testosterone undecanoate demonstrated a nominal statistically significantly greater mean change from baseline than 1.62% topical testosterone gel for Short Form‐36v2 Health Survey measures of mental health (2.91 vs. ‐0.10; <jats:italic>p </jats:italic>= 0.035), and mental component summary (3.82 vs. 0.55; <jats:italic>p </jats:italic>= 0.009); and Psychosexual Daily Questionnaire measure of weekly negative mood (‐0.57 vs. ‐0.20; <jats:italic>p </jats:italic>= 0.021). Safety endpoints were comparable between therapies. No deaths or treatment‐related serious adverse events were reported.Discussion and conclusionMale patients with hypogonadism receiving oral testosterone undecanoate 225 mg twice daily demonstrated improvements in libido and sexual frequency. Serum testosterone concentrations were within the reference range in 87% of patients without dose titration.","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"6 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142224416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capacitation of ram spermatozoa promotes changes in energy metabolism and aquaporin 3 and is affected by individual testosterone variations. 公羊精子的能力促进能量代谢和水蒸气素 3 的变化,并受个体睾酮变化的影响。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-06 DOI: 10.1111/andr.13756
Patricia Peris-Frau, Ana Sanchez-Rodriguez, Rosario Velázquez, Adolfo Toledano-Díaz, Cristina Castaño, Eduardo R S Roldan, Julián Santiago-Moreno

Background: Recently, the metabolic pathways involved in energy production and the role of aquaglyceroporins in capacitation-associated events have been studied in humans and mice. However, little is known about these in ram spermatozoa.

Objective: The present study investigated bioenergetic and aquaglyceroporin 3 variations during in vitro capacitation of ram spermatozoa. In addition, differences in testosterone levels between males were examined to determine their influence on capacitation-like changes.

Materials and methods: Spermatozoa obtained from nine rams (ejaculates = 36) were incubated for 180 min in three different media (control, capacitating, and aquaglyceroporin-inhibitor media) at 38.5°C. At 0 and 180 min of incubation in each medium, sperm viability, kinetics, chlortetracycline patterns, adenosine triphosphate concentration, lactate excretion (final subproduct of glycolysis), and immunolocalization of aquaporin 3 were evaluated.

Results: The increment of the capacitated spermatozoa-chlortetracycline pattern and the hyperactivated-like movement characterized by the highest curvilinear velocity and amplitude of lateral head displacement and the lowest linearity was only recorded after 180 min in the capacitating medium. At this time and conditions, adenosine triphosphate content and lactate excretion decreased, whereas the aquaglyceroporin 3 location in the midpiece and principal piece increased compared to 0 min. Such changes were not observed in the control medium over time. Incubation in the aquaglyceroporin-inhibitor medium for 180 min reduced drastically sperm motility and adenosine triphosphate content compared to the other media. Testosterone analysis revealed a significant individual variability, which was also present in all sperm parameters evaluated. Furthermore, testosterone was negatively correlated with adenosine triphosphate content but positively correlated with lactate excretion levels, sperm viability, motility, capacitated sperm-chlortetracycline pattern, and aquaglyceroporin 3 immunolabeling in the midpiece and principal piece.

Conclusion: Despite individual differences, capacitation of ram spermatozoa increases adenosine triphosphate consumption, energy metabolism, and aquaglyceroporin 3 location in the midpiece and principal piece, which seems to be related to the acquisition of hyperactivated-like motility. Furthermore, testosterone levels may serve as a valuable tool to select those males with a greater sperm metabolism rate and fertilizing capacity.

背景:最近,人类和小鼠对能量产生所涉及的代谢途径以及水甘油多肽在获能相关事件中的作用进行了研究。然而,人们对公羊精子中的这些情况知之甚少:本研究调查了公羊精子体外获能过程中生物能和水甘油三酯的变化。此外,还研究了雄性之间睾酮水平的差异,以确定其对获能样变化的影响:在38.5°C的三种不同培养基(对照培养基、获能培养基和水甘油三酯抑制剂培养基)中培养9只公羊(射精量=36)的精子180分钟。在每种培养基中培养 0 分钟和 180 分钟后,对精子活力、动力学、金霉素模式、三磷酸腺苷浓度、乳酸排泄(糖酵解的最终副产物)和水华素 3 的免疫定位进行评估:结果:在获能培养基中培养 180 分钟后,才记录到获能精子-金霉素模式和超活化运动的增加,超活化运动的特点是头部侧向位移的曲线速度和振幅最大,线性度最小。在此时间和条件下,三磷酸腺苷含量和乳酸盐排泄量减少,而中片和主片的水甘油三酯位置与 0 分钟相比有所增加。在对照组培养基中,随着时间的推移没有观察到这种变化。与其他培养基相比,在水甘油三酯抑制剂培养基中培养 180 分钟会大幅降低精子活力和三磷酸腺苷含量。睾酮分析表明,精子的个体差异很大,这也存在于所有精子参数的评估中。此外,睾酮与三磷酸腺苷含量呈负相关,但与乳酸排泄水平、精子存活率、运动能力、获能精子-金霉素模式以及中段和主片的水甘油三酯免疫标记呈正相关:结论:尽管存在个体差异,但公羊精子的获能过程会增加三磷酸腺苷的消耗、能量代谢以及中段和主片的水甘油三酯位置,这似乎与获得超活化运动能力有关。此外,睾酮水平可作为选择精子代谢率和受精能力较高的雄性的重要工具。
{"title":"Capacitation of ram spermatozoa promotes changes in energy metabolism and aquaporin 3 and is affected by individual testosterone variations.","authors":"Patricia Peris-Frau, Ana Sanchez-Rodriguez, Rosario Velázquez, Adolfo Toledano-Díaz, Cristina Castaño, Eduardo R S Roldan, Julián Santiago-Moreno","doi":"10.1111/andr.13756","DOIUrl":"https://doi.org/10.1111/andr.13756","url":null,"abstract":"<p><strong>Background: </strong>Recently, the metabolic pathways involved in energy production and the role of aquaglyceroporins in capacitation-associated events have been studied in humans and mice. However, little is known about these in ram spermatozoa.</p><p><strong>Objective: </strong>The present study investigated bioenergetic and aquaglyceroporin 3 variations during in vitro capacitation of ram spermatozoa. In addition, differences in testosterone levels between males were examined to determine their influence on capacitation-like changes.</p><p><strong>Materials and methods: </strong>Spermatozoa obtained from nine rams (ejaculates = 36) were incubated for 180 min in three different media (control, capacitating, and aquaglyceroporin-inhibitor media) at 38.5°C. At 0 and 180 min of incubation in each medium, sperm viability, kinetics, chlortetracycline patterns, adenosine triphosphate concentration, lactate excretion (final subproduct of glycolysis), and immunolocalization of aquaporin 3 were evaluated.</p><p><strong>Results: </strong>The increment of the capacitated spermatozoa-chlortetracycline pattern and the hyperactivated-like movement characterized by the highest curvilinear velocity and amplitude of lateral head displacement and the lowest linearity was only recorded after 180 min in the capacitating medium. At this time and conditions, adenosine triphosphate content and lactate excretion decreased, whereas the aquaglyceroporin 3 location in the midpiece and principal piece increased compared to 0 min. Such changes were not observed in the control medium over time. Incubation in the aquaglyceroporin-inhibitor medium for 180 min reduced drastically sperm motility and adenosine triphosphate content compared to the other media. Testosterone analysis revealed a significant individual variability, which was also present in all sperm parameters evaluated. Furthermore, testosterone was negatively correlated with adenosine triphosphate content but positively correlated with lactate excretion levels, sperm viability, motility, capacitated sperm-chlortetracycline pattern, and aquaglyceroporin 3 immunolabeling in the midpiece and principal piece.</p><p><strong>Conclusion: </strong>Despite individual differences, capacitation of ram spermatozoa increases adenosine triphosphate consumption, energy metabolism, and aquaglyceroporin 3 location in the midpiece and principal piece, which seems to be related to the acquisition of hyperactivated-like motility. Furthermore, testosterone levels may serve as a valuable tool to select those males with a greater sperm metabolism rate and fertilizing capacity.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of sperm DNA fragmentation on the cumulative live birth rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection treatment. 精子 DNA 片段对体外受精/卵胞浆内单精子注射治疗患者累积活产率的影响。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-05 DOI: 10.1111/andr.13754
Zaiqing Qu, Di Zhao, Longda Wang, Shiyu Yang, Shuhua Zhao

Background: Sperm DNA fragmentation testing is a valuable tool for predicting male infertility independent of routine semen analysis. However, it remains unclear whether sperm DNA fragmentation affects in vitro fertilization/intracytoplasmic sperm injection outcomes, especially their live birth rates. This study aimed to investigate the effects of sperm DNA fragmentation on the cumulative live birth rates over 1 year of in vitro fertilization/intracytoplasmic sperm injection treatment.

Methods: This retrospective study included 5050 couples who had undergone in vitro fertilization/intracytoplasmic sperm injection treatment from 2016 to 2022. These patients were divided into four groups according to their sperm DNA fragmentation percentages (group 1: sperm DNA fragmentation ≤10%, group 2: > 10% to ≤20%, group3: > 20% to ≤30%, and group 4: > 30%) determined using the sperm chromatin dispersion assay. Both conservative and optimistic methods were used for estimating cumulative live birth rates, the primary outcome, was defined as an ongoing pregnancy leading to live birth that had arisen from all embryo transfers performed within 1 year following the first ovum pick-up.

Results: The conservative and optimistic cumulative live birth rates showed no significant differences between sperm DNA fragmentation groups when total patients or in vitro fertilization patients were analyzed while adjusting for the confounders. However, compared with those in the group with low sperm DNA fragmentation values (≤10%), the conservative cumulative live birth rate was significantly decreased in intracytoplasmic sperm injection patients in the group with sperm DNA fragmentation > 30%, and the optimistic cumulative live birth rates were significantly decreased in intracytoplasmic sperm injection patients in the three groups with high sperm DNA fragmentation values (> 10% to ≤20%, > 20% to ≤30%, > 30%). These results were further confirmed by the analyses of smooth curves generated by generalized additive models. In intracytoplasmic sperm injection patients, the cumulative live birth rates decreased significantly as the sperm DNA fragmentation increased (p = 0.034), and these effects were stronger with the increase in female age. A similar pattern of correlation between sperm DNA fragmentation and cumulative live birth rate was found in in vitro fertilization patients, but the correlation was not significant (p = 0.232).

Discussion and conclusion: Sperm DNA fragmentation has a significant effect on the cumulative probability of achieving a live birth during 1 year of treatment involving intracytoplasmic sperm injection.

背景:精子DNA片段检测是一种独立于常规精液分析的预测男性不育症的重要工具。然而,精子DNA片段是否会影响体外受精/卵胞浆内单精子注射的结果,尤其是其活产率,目前仍不清楚。本研究旨在探讨精子DNA片段对体外受精/卵胞浆内单精子注射治疗一年内累积活产率的影响:这项回顾性研究纳入了2016年至2022年期间接受体外受精/卵胞浆内单精子注射治疗的5050对夫妇。这些患者根据精子DNA碎片百分比被分为四组(第1组:精子DNA碎片≤10%,第2组:>10%至≤20%,第3组:>10%至≤20%,第4组:>10%至≤20%):>10%至≤20%,第3组:>20%至≤30%:>20%至≤30%,第4组:>30%)。在估算累积活产率时,采用了保守和乐观两种方法。累积活产率是指在第一次取卵后 1 年内进行的所有胚胎移植所产生的、导致活产的持续妊娠:在对混杂因素进行调整后,对所有患者或体外受精患者进行分析,精子DNA片段组与保守组和乐观组的累积活产率没有明显差异。然而,与精子DNA片段值低(≤10%)组相比,精子DNA片段值>30%组的卵胞浆内单精子注射患者的保守累积活产率明显降低,而精子DNA片段值高(>10%至≤20%,>20%至≤30%,>30%)的三组卵胞浆内单精子注射患者的乐观累积活产率明显降低。用广义加性模型生成的平滑曲线分析进一步证实了这些结果。在卵胞浆内单精子注射患者中,随着精子 DNA 碎片率的增加,累积活产率显著下降(p = 0.034),而且随着女性年龄的增加,这些影响更强。在体外受精患者中,精子DNA片段与累积活产率之间也存在类似的相关性,但相关性不显著(P = 0.232):精子 DNA 片段对卵胞浆内单精子注射治疗 1 年内获得活产的累积概率有显著影响。
{"title":"Effect of sperm DNA fragmentation on the cumulative live birth rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection treatment.","authors":"Zaiqing Qu, Di Zhao, Longda Wang, Shiyu Yang, Shuhua Zhao","doi":"10.1111/andr.13754","DOIUrl":"https://doi.org/10.1111/andr.13754","url":null,"abstract":"<p><strong>Background: </strong>Sperm DNA fragmentation testing is a valuable tool for predicting male infertility independent of routine semen analysis. However, it remains unclear whether sperm DNA fragmentation affects in vitro fertilization/intracytoplasmic sperm injection outcomes, especially their live birth rates. This study aimed to investigate the effects of sperm DNA fragmentation on the cumulative live birth rates over 1 year of in vitro fertilization/intracytoplasmic sperm injection treatment.</p><p><strong>Methods: </strong>This retrospective study included 5050 couples who had undergone in vitro fertilization/intracytoplasmic sperm injection treatment from 2016 to 2022. These patients were divided into four groups according to their sperm DNA fragmentation percentages (group 1: sperm DNA fragmentation ≤10%, group 2: > 10% to ≤20%, group3: > 20% to ≤30%, and group 4: > 30%) determined using the sperm chromatin dispersion assay. Both conservative and optimistic methods were used for estimating cumulative live birth rates, the primary outcome, was defined as an ongoing pregnancy leading to live birth that had arisen from all embryo transfers performed within 1 year following the first ovum pick-up.</p><p><strong>Results: </strong>The conservative and optimistic cumulative live birth rates showed no significant differences between sperm DNA fragmentation groups when total patients or in vitro fertilization patients were analyzed while adjusting for the confounders. However, compared with those in the group with low sperm DNA fragmentation values (≤10%), the conservative cumulative live birth rate was significantly decreased in intracytoplasmic sperm injection patients in the group with sperm DNA fragmentation > 30%, and the optimistic cumulative live birth rates were significantly decreased in intracytoplasmic sperm injection patients in the three groups with high sperm DNA fragmentation values (> 10% to ≤20%, > 20% to ≤30%, > 30%). These results were further confirmed by the analyses of smooth curves generated by generalized additive models. In intracytoplasmic sperm injection patients, the cumulative live birth rates decreased significantly as the sperm DNA fragmentation increased (p = 0.034), and these effects were stronger with the increase in female age. A similar pattern of correlation between sperm DNA fragmentation and cumulative live birth rate was found in in vitro fertilization patients, but the correlation was not significant (p = 0.232).</p><p><strong>Discussion and conclusion: </strong>Sperm DNA fragmentation has a significant effect on the cumulative probability of achieving a live birth during 1 year of treatment involving intracytoplasmic sperm injection.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142131665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in anejaculation: A randomized controlled trial. 重复经颅磁刺激(rTMS)对无射精症的疗效和安全性:随机对照试验。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-04 DOI: 10.1111/andr.13752
Ming Wang, Qiushi Liu, Hui Gao, Dangwei Peng, Weinan Wang, Juncheng Ma, Zihang Chen, Wangheng Zhang, Tommaso B Jannini, Emmanuele A Jannini, Hui Jiang, Xiansheng Zhang

Background: Anejaculation represents significant psychological distress and sexual and reproductive challenges among male individuals and couples. Effective fertility management options are available to address the reproductive challenges associated with anejaculation. However, there is a lack of methods to reverse the condition itself.

Objectives: This study aims to assess the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in patients suffering from anejaculation.

Methods: A total of 94 patients with anejaculation individuals were randomly assigned to receive high-frequency (HF) stimulation on the left dorsolateral prefrontal cortex (DLPFC), low-frequency (LF) stimulation on the right DLPFC, and sham stimulation for 4 weeks, with daily sessions of stimulation occurring on five consecutive weekdays each week.

Results: After 4 weeks of rTMS treatment, the patients in both the HF and LF groups exhibited a similar reduction in their male sexual health questionnaire for ejaculatory dysfunction bother/satisfaction score, Hamilton Anxiety Scale score, Hamilton Depression Scale score, and Pittsburgh Sleep Quality Inventory score, which were statistically significant compared with sham treatment. Additionally, there were no significant differences observed in erectile function and cognitive function across the three groups. However, there were notable disparities in the cure rates between HF- and LF-group patients (16.1% vs. 54.8%, p = 0.001). Additionally, it is worth noting that only two HF group patients and one LF group patient experienced spontaneously resolving minor adverse effects during the treatment process. At the 8-week follow-up, among patients who initially responded to the treatment, only one from the HF group experienced a relapse.

Discussion and conclusion: The findings of this study demonstrate that rTMS represents a secure and efficacious remedy for anejaculation patients.

背景:在男性个体和夫妇中,遗精代表着严重的心理困扰以及性和生殖方面的挑战。目前已有有效的生育管理方案来应对与遗精相关的生殖挑战。然而,目前还缺乏扭转这种情况的方法:本研究旨在评估重复经颅磁刺激(rTMS)对无射精症患者的有效性和安全性:共有94名射精障碍患者被随机分配接受左侧背外侧前额叶皮层(DLPFC)的高频(HF)刺激、右侧DLPFC的低频(LF)刺激和假刺激,为期4周,每周连续5个工作日进行每日刺激:经颅磁刺激治疗4周后,高频组和低频组患者的男性性健康问卷中射精功能障碍困扰/满意度评分、汉密尔顿焦虑量表评分、汉密尔顿抑郁量表评分和匹兹堡睡眠质量量表评分均有类似程度的下降,与假治疗相比具有统计学意义。此外,在勃起功能和认知功能方面,三组之间没有观察到明显差异。不过,高频组和低频组患者的治愈率存在明显差异(16.1% 对 54.8%,P = 0.001)。此外,值得注意的是,只有两名高频组患者和一名低频组患者在治疗过程中出现了自发缓解的轻微不良反应。在 8 周的随访中,最初对治疗有反应的高频组患者中只有一人复发:本研究结果表明,经颅磁刺激是治疗不射精症患者的一种安全有效的方法。
{"title":"Efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in anejaculation: A randomized controlled trial.","authors":"Ming Wang, Qiushi Liu, Hui Gao, Dangwei Peng, Weinan Wang, Juncheng Ma, Zihang Chen, Wangheng Zhang, Tommaso B Jannini, Emmanuele A Jannini, Hui Jiang, Xiansheng Zhang","doi":"10.1111/andr.13752","DOIUrl":"https://doi.org/10.1111/andr.13752","url":null,"abstract":"<p><strong>Background: </strong>Anejaculation represents significant psychological distress and sexual and reproductive challenges among male individuals and couples. Effective fertility management options are available to address the reproductive challenges associated with anejaculation. However, there is a lack of methods to reverse the condition itself.</p><p><strong>Objectives: </strong>This study aims to assess the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in patients suffering from anejaculation.</p><p><strong>Methods: </strong>A total of 94 patients with anejaculation individuals were randomly assigned to receive high-frequency (HF) stimulation on the left dorsolateral prefrontal cortex (DLPFC), low-frequency (LF) stimulation on the right DLPFC, and sham stimulation for 4 weeks, with daily sessions of stimulation occurring on five consecutive weekdays each week.</p><p><strong>Results: </strong>After 4 weeks of rTMS treatment, the patients in both the HF and LF groups exhibited a similar reduction in their male sexual health questionnaire for ejaculatory dysfunction bother/satisfaction score, Hamilton Anxiety Scale score, Hamilton Depression Scale score, and Pittsburgh Sleep Quality Inventory score, which were statistically significant compared with sham treatment. Additionally, there were no significant differences observed in erectile function and cognitive function across the three groups. However, there were notable disparities in the cure rates between HF- and LF-group patients (16.1% vs. 54.8%, p = 0.001). Additionally, it is worth noting that only two HF group patients and one LF group patient experienced spontaneously resolving minor adverse effects during the treatment process. At the 8-week follow-up, among patients who initially responded to the treatment, only one from the HF group experienced a relapse.</p><p><strong>Discussion and conclusion: </strong>The findings of this study demonstrate that rTMS represents a secure and efficacious remedy for anejaculation patients.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraindividual variability of semen quality, proteome, and sncRNA profiles in a healthy cohort of young adults. 健康青壮年群体精液质量、蛋白质组和 sncRNA 图谱的个体内差异性。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-04 DOI: 10.1111/andr.13739
Oleg Sergeyev, Vitalik Bezuglov, Natalia Soloveva, Luidmila Smigulina, Tatiana Denisova, Yury Dikov, Victoria Shtratnikova, Nikita Vavilov, Paige L Williams, Susan Korrick, Mary M Lee, Victor Zgoda, Russ Hauser, Alexander Suvorov

Background: Within-subject variability of semen parameters and molecular components of ejaculates in young men remains poorly understood.

Objectives: To investigate intraindividual variability (IIV) of semen parameters and molecular markers in repeated ejaculates from young men.

Materials and methods: Semen parameters were assessed in samples collected 6-8 days apart from 164 18-19-year old participants of the Russian Children's Study, a prospective cohort. Subsets of paired samples were used for label-free quantitation and targeted mass-spectrometry of proteins in seminal plasma (SP) and seminal extracellular vesicles (EVs), and for small non-coding RNA (sncRNA) profiling in EVs and spermatozoa using RNA-seq. The mean difference between two ejaculates, within-subject variation, intraclass correlation, and concordance correlation were used to assess IIV for all parameters. Low variability with high reproducibility and high reliability was considered if CVw < 15% and ICC > 0.90, respectively.

Results: Analytical variability was low for all investigated parameters in technical replicates. IIV was assessed for basic semen parameters and proteins in SPs and EVs: 319 and 777 proteins, respectively, using untargeted analysis; 9 and 10 proteins using targeted quantification. We also described the IIV for sncRNA, including microRNA, piwi-interacting RNA, tRNA, and tRNA-derived small RNA (tsRNA) in EVs (409 sncRNA and 78 tsRNA) and in spermatozoa (265 sncRNA and 15 tsRNA). We identified 22 and 27 non-overlapping proteins in SP and EVs, respectively, and 46 and 9 sncRNA, including 5 and 0 tsRNA in seminal EVs and spermatozoa, respectively, with low variability. The fatty acid synthase (FAS) had the lowest IIV in both media in targeted protein quantification.

Discussion: We identified a number of proteins and sncRNA with low variability among 111 proteins, 176 sncRNA, and 12 tsRNA which were previously suggested as biomarkers of male fertility and reproductive outcomes: lactotransferrin, cysteine-rich secretory protein 3, alpha-1-antichymotrypsin, epididymal sperm-binding protein 1, glutathione S-transferase Mu 3, alpha-1-acid glycoprotein 2, serum amyloid P-component, aminopeptidase N, neprilysin, FAS, and miR-10b-3p, miR-122-5p, miR-205-5p, miR-222-3p, miR-34c-5p, miR-509-3-5p, miR-888-5p, miR-892a, miR-363-3p, miR-941, miR-146a-5p, miR-744-5p.

Conclusion: These molecules have low IIV and may be promising candidate biomarkers of male fertility and reproductive health.

背景:对年轻男性精液参数和射精分子成分的受试者内变异性仍然知之甚少:研究年轻男性重复射精中精液参数和分子标记物的个体内变异性(IIV):对俄罗斯儿童研究(一项前瞻性队列研究)中 164 名 18-19 岁参与者的精液参数进行评估。使用配对样本的子集对精浆(SP)和精液细胞外囊泡(EVs)中的蛋白质进行无标记定量和靶向质谱分析,并使用 RNA-seq 对 EVs 和精子中的小非编码 RNA(sncRNA)进行分析。采用两次射精的平均差、受试者内变异、类内相关性和一致性相关性来评估所有参数的 IIV。如果 CVw 为 0.90,则认为变异性低,可重复性高,可靠性高:在技术重复中,所有研究参数的分析变异性都很低。对精液基本参数以及 SPs 和 EVs 中的蛋白质进行了 IIV 评估:使用非靶向分析分别检测了 319 和 777 个蛋白质;使用靶向定量分别检测了 9 和 10 个蛋白质。我们还描述了 EV(409 个 sncRNA 和 78 个 tsRNA)和精子(265 个 sncRNA 和 15 个 tsRNA)中 sncRNA(包括 microRNA、piwi-interacting RNA、tRNA 和 tRNA 衍生的小 RNA (tsRNA))的 IIV。我们在 SP 和 EV 中分别发现了 22 和 27 个非重叠蛋白,在精液 EV 和精子中分别发现了 46 和 9 个 sncRNA,包括 5 和 0 个 tsRNA,其变异性较低。在两种介质中,脂肪酸合成酶(FAS)的目标蛋白定量的 IIV 最低:讨论:在之前被认为是男性生育能力和生殖结果生物标志物的 111 种蛋白质、176 种 sncRNA 和 12 种 tsRNA 中,我们发现了一些变异性较低的蛋白质和 sncRNA:乳转铁蛋白、富半胱氨酸分泌蛋白 3、α-1-antichymotrypsin、附睾精子结合蛋白 1、谷胱甘肽 S-transferase Mu 3、α-1-酸性糖蛋白 2、血清淀粉样蛋白 P-成分、氨肽酶 N、nemiR-10b-3p、miR-122-5p、miR-205-5p、miR-222-3p、miR-34c-5p、miR-509-3-5p、miR-888-5p、miR-892a、miR-363-3p、miR-941、miR-146a-5p、miR-744-5p。结论这些分子的 IIV 值较低,有可能成为男性生育能力和生殖健康的候选生物标志物。
{"title":"Intraindividual variability of semen quality, proteome, and sncRNA profiles in a healthy cohort of young adults.","authors":"Oleg Sergeyev, Vitalik Bezuglov, Natalia Soloveva, Luidmila Smigulina, Tatiana Denisova, Yury Dikov, Victoria Shtratnikova, Nikita Vavilov, Paige L Williams, Susan Korrick, Mary M Lee, Victor Zgoda, Russ Hauser, Alexander Suvorov","doi":"10.1111/andr.13739","DOIUrl":"https://doi.org/10.1111/andr.13739","url":null,"abstract":"<p><strong>Background: </strong>Within-subject variability of semen parameters and molecular components of ejaculates in young men remains poorly understood.</p><p><strong>Objectives: </strong>To investigate intraindividual variability (IIV) of semen parameters and molecular markers in repeated ejaculates from young men.</p><p><strong>Materials and methods: </strong>Semen parameters were assessed in samples collected 6-8 days apart from 164 18-19-year old participants of the Russian Children's Study, a prospective cohort. Subsets of paired samples were used for label-free quantitation and targeted mass-spectrometry of proteins in seminal plasma (SP) and seminal extracellular vesicles (EVs), and for small non-coding RNA (sncRNA) profiling in EVs and spermatozoa using RNA-seq. The mean difference between two ejaculates, within-subject variation, intraclass correlation, and concordance correlation were used to assess IIV for all parameters. Low variability with high reproducibility and high reliability was considered if CV<sub>w</sub> < 15% and ICC > 0.90, respectively.</p><p><strong>Results: </strong>Analytical variability was low for all investigated parameters in technical replicates. IIV was assessed for basic semen parameters and proteins in SPs and EVs: 319 and 777 proteins, respectively, using untargeted analysis; 9 and 10 proteins using targeted quantification. We also described the IIV for sncRNA, including microRNA, piwi-interacting RNA, tRNA, and tRNA-derived small RNA (tsRNA) in EVs (409 sncRNA and 78 tsRNA) and in spermatozoa (265 sncRNA and 15 tsRNA). We identified 22 and 27 non-overlapping proteins in SP and EVs, respectively, and 46 and 9 sncRNA, including 5 and 0 tsRNA in seminal EVs and spermatozoa, respectively, with low variability. The fatty acid synthase (FAS) had the lowest IIV in both media in targeted protein quantification.</p><p><strong>Discussion: </strong>We identified a number of proteins and sncRNA with low variability among 111 proteins, 176 sncRNA, and 12 tsRNA which were previously suggested as biomarkers of male fertility and reproductive outcomes: lactotransferrin, cysteine-rich secretory protein 3, alpha-1-antichymotrypsin, epididymal sperm-binding protein 1, glutathione S-transferase Mu 3, alpha-1-acid glycoprotein 2, serum amyloid P-component, aminopeptidase N, neprilysin, FAS, and miR-10b-3p, miR-122-5p, miR-205-5p, miR-222-3p, miR-34c-5p, miR-509-3-5p, miR-888-5p, miR-892a, miR-363-3p, miR-941, miR-146a-5p, miR-744-5p.</p><p><strong>Conclusion: </strong>These molecules have low IIV and may be promising candidate biomarkers of male fertility and reproductive health.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Welcome 特刊:第 13 届欧洲 Andrology 大会,2024 年 9 月 4-6 日,瑞典斯德哥尔摩。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-02 DOI: 10.1111/andr.13710
{"title":"Welcome","authors":"","doi":"10.1111/andr.13710","DOIUrl":"10.1111/andr.13710","url":null,"abstract":"","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"12 S2","pages":"3-4"},"PeriodicalIF":3.2,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scientific Program 特刊:第 13 届欧洲 Andrology 大会,2024 年 9 月 4-6 日,瑞典斯德哥尔摩。
IF 3.2 2区 医学 Q1 ANDROLOGY Pub Date : 2024-09-02 DOI: 10.1111/andr.13711
{"title":"Scientific Program","authors":"","doi":"10.1111/andr.13711","DOIUrl":"10.1111/andr.13711","url":null,"abstract":"","PeriodicalId":7898,"journal":{"name":"Andrology","volume":"12 S2","pages":"5-10"},"PeriodicalIF":3.2,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Andrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1